in intracerebral haemorrhage (ICH). Our study aimed to assess the prevalence of stress hyperglycaemia in the acute phase of ICH and its impact on in-hospital mortality.
Methods: This was a retrospective descriptive study with analytical and descriptive purposes in the medical emergency and neurology departments of the Yalgado Ouedraogo University Hospital over 2 years from 1st January 2021 to 31st December 2022. Non-diabetic patients with ICH and fasting hyperglycaemia ≥ 7mmo/l on admission and glycated haemoglobin < 6.5% were included. Bivariate and multivariate analyses were used to assess the impact of stress hyperglycaemia on mortality.
Results: We included 199 patients. The mean age of the patients was 55.72±13.3y and the male: female ratio was 1.58. Arterial hypertension was the main aetiology of ICH in 86.9% (n=173) of cases. The mortality rate was 23.1% (n=46). The prevalence of stress hyperglycaemia in the acute phase of stroke was 52.3% (n=104). Factors associated with higher hospital mortality were admission hyperglycaemia ≥ 7mmo/l (p= 0.0017) and National Institutes of Health Stroke Scale ≥ 17 (p= 0.0136).
Conclusion: Mortality in ICH remains high. Stress hyperglycaemia has a high prevalence and is a poor prognostic factor in ICH.
Intracerebral haemorrhage, stress hyperglycaemia, mortality